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Background: Rotavirus infections are a major cause of diarrhea in children in both developed and developing
countries. Rotavirus genetics, patient immunity, and environmental factors are thought to be related to the severity
of acute diarrhea due to rotavirus in infants and young children. The objective of this study was to provide a
correlation between rotavirus genotypes, clinical factors and degree of severity of acute diarrhea in children under
5 years old in Surabaya, Indonesia.
Methods: A cross-sectional study was conducted in children aged 1–60 months with acute diarrhea hospitalized in
Soetomo Hospital, Surabaya, Indonesia from April to December 2013. Rotavirus in stool specimens was identified by
ELISA and genotyping (G-type and P-type) using multiplex reverse transcription PCR. Severity was measured using
the Ruuska and Vesikari scoring system. The clinical factors were investigated included patient’s age (months),
hydration, antibiotic administration, nutritional state, co-bacterial infection and co-viral infection.
Results: A total of 88 children met the criteria; 80.7% were aged 6–24 months, watery diarrhea was the most common
type (77.3%) and 73.6% of the subjects were co-infected with bacteria, of which pathogenic Escherichia coli was the
most common (42.5%). The predominant VP7 genotyping (G-type) was G2 (31.8%) and that of VP4 genotyping (P-type)
was P[4] (31.8%). The predominant rotavirus genotype was G2P[4] (19.3%); G1P[4] and G9P[4] were uncommon with a
prevalence of 4.5%. There were significant differences between the common genotype and uncommon genotype with
respect to the total severity score of diarrhea (p <0.05). G3, G4 and G9 were significantly correlated with severe diarrhea
(p = 0.009) in multivariate analyses and with frequency of diarrhea (>10 times a day) (p = 0.045) in univariate analyses,
but there was no significant correlation between P typing and severity of diarrhea. For combination genotyping of G
and P, G2P[4] was significantly correlated with severe diarrhea in multivariate analyses (p = 0.029).
Conclusions: There is a correlation between rotavirus genotype and severity of acute diarrhea in children. Genotype
G2P[4] has the highest prevalence. G3, G4, G9 and G2P[4] combination genotype were found to be associated with
severe diarrhea.
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Pediatric diarrhea is often fatal since this disease results
in severe dehydration [1]. There are several causes of
pediatric diarrhea including bacterial or viral infectious
diseases. As to the latter, several pathogens such as
rotavirus, adenovirus and norovirus are reported [2-4].
Rotavirus is the most commonly isolated viral cause of
severe diarrhea in infants, infecting more than 111
million pediatric patients every year and causing an es-
timated 440,000 deaths [4-6]. Rotavirus genetic factors,
patient’s immune factors, and environmental factors are
associated with the incidence and severity of acute diar-
rhea due to rotavirus in infants and toddlers [7].
Viral typing is necessary for characterizing rotavirus
strains, especially focusing on different rotavirus seasons
in different locations. G-typing is categorized as G1-16,
the double combination of G1-16G1-16, and the triple
combination G1-16G1-16G1-16 [8]. P-typing is classified
to into P1-28, the double combination of P1-28P1-28, and
triple combination of P1-28P1-28P1-28 [8]. Moreover,
whole genotyping is sometimes shown as the combination
of G type and P type [8]. VP7 and VP4 proteins are the
basis of the classification of group A rotaviruses by G
(VP7) and P (VP4) types; G represents glycoprotein and P
represents protease sensitive protein [8,9]. G1P[8], G2P
[4], G3P[8], and G4P[8] were the four dominant and most
commonly found genotypes worldwide from 1994 to 2003
[10,11]. Generally, in human rotavirus, G1 to G4 and G9
in VP7 and P[4] and P[8] in VP4 are the most common
types. Combined G and P typing represents a limited
number of genotypes such as G2P[4], G3P[8], G4P[8],
G9P[8], and G1P[8] [11]. Those types vary from region to
region (e.g. G5 types in Brazil, G10 types in India) [12,13].
Till date 27 G genotypes, 37 P genotypes and 73 different
combinations of G and P genotypes have been reported
[14,15]. Putnam et al. found G9P [8] to be the most com-
mon genotype with a prevalence of 13.57% in 2003–2004
in Indonesia, but Soenarto et al. detected G1P[6] as the
dominant genotype (34%) in Indonesia in 2006 [16,17].
New rotavirus genotypes have been found, causing more
severe diarrhea than previously identified rotavirus geno-
types [18-23].
Flores et al. studying the efficacy of rotavirus vaccine
(RIT 4237) on diarrheal disease, formulated a scoring
system for the severity of diarrhea in infants and tod-
dlers with or without vaccination [24]. The scoring sys-
tem was used by Cascio et al. to assess differences in the
severity of diarrhea experienced by children in Italy
who were infected by rotavirus of different strains [19].
Ruuska and Vesikari [22] developed the scoring system by
combining more variables includes episodes of vomiting
in 24 hours [25]. Its validity and reliability was verified
with a significant correlation between scores and the im-
pact of diarrheal disease on the family [26]. Mota-Hernandez et al. utilized such scoring system to assess the
severity of diarrhea in children caused by rotavirus in-
fection with different genotypes of VP4 gene, unidenti-
fied P type (new P type) and type P[8] [21]. Zhang et al.
also stated that rotavirus diarrhea caused by G1 was as-
sociated with higher severity scores than diarrhea
caused by G3 in their study of rotavirus genotypes and
disease severity [27]. This scoring system was also used
to assess the relationship between rotavirus genotypes
and the severity of diarrhea in a population of children
in India [28].
Host factors are also very important in infections. Im-
mune status and nutrition affect host responses to bac-
terial and viral pathogens [29,30]. Compared to bacteria,
the infectious potential of viruses in humans is compara-
tive and the host’s defenses are essential for prevention
[31,32]. Environmental issues such as drinking water,
hand washing and family income also play a role in the
prevention of infectious disease [33].
In this study, we sought the correlation between rota-
virus genotypes, clinical factors and degree of severity of
acute diarrhea in children under 5 years old in Surabaya,
Indonesia.Methods
Patients
For one year surveillance, the data and the stool samples
were gathered from April to December 2013. A total of
220 stool specimens were collected from the inpatients
diagnosed with acute diarrhea in the Department of
Pediatrics, Soetomo Hospital, Surabaya, Indonesia. The
stools samples were from the consecutive patients in this
studied time. The children with chronic diarrheas were
excluded from the study.
PCR examination was done in 88 patients who had posi-
tive immunochromatography tests for virus detection.
The study was approved by the Health Research Ethics
Committee of Soetomo Hospital. Research subjects were
all patients hospitalized in the Gastroenterology Ward in
Department of Pediatrics of Soetomo Hospital. Inclusion
criteria: children between 1–60 months with positive
results from rotavirus antigen examination. Patients
were excluded from the study if they were treated with
antibiotics, probiotics and zinc before hospitalization,
or had a history of rotavirus immunization or were in
an immunocompromized condition (eg. from long term
steroid therapy or cytostatic agents), who refused to
continue the study. All study subjects underwent a
physical examination, and parents or caretakers filled
out a questionnaire. Stool specimens were collected
and sent to the laboratory in Institute of Tropical
Disease within 24 hours for bacterial culture and
rotavirus molecular biology studies.
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Stool rotavirus was examined by immunochromatographic
methods (BD Rota/AdenoExamine™ kit), BD Biosciences,
San Jose, CA. Stool samples were selected for rotavirus
genotyping by a two-step RT-PCR method and included
to the study by randomization from rotavirus positive
stool samples [34]. The viral RNA was extracted using
Viral Nucleic Acid Extraction Kit II (Geneaid Biotech Ltd.,
New Taipei) according to the manufacturer’s protocol.
Two-step reverse transcription-PCR (RT-PCR) was carried
out with the ThermoScript™ RT-PCR system to synthesize
cDNA corresponding to the genomic segments encoding
VP7 and VP4 with the protocol recommendation by the
company. Used PCR primers are shown in Table 1. As to
G typing, the primers VP7F and VP7R were used in RT-
PCR (30 cycles) for an 881-bp VP7 gene segment. Then,
VP7F was used in PCR (30 cycles) with type-specific such
primers as aBT1 (G1), aCT-2 (G2), G3 (G3), aDT4 (G4),
aAT8 (G8) and aFT9 (G9). For P-typing, the primers VP4F
and VP4R were used in RT-PCR (30 cycles) for a 663-bp
fragment and VP4F was then used in PCR (30 cycles) with
such type-specific primers as 1T-1D (P[8]), 2T-1 (P[4]),
3T-1(P[6]), 4T-1 (P[9]) and 5T-1 (P[10]). Primers corre-
sponding to the VP7 and VP4 genes for rotavirus geno-
typing were obtained from Integrated DNA Technologies,
Singapore. All PCR products were separated in 2% agaroseTable 1 Primers correspond to VP7 and VP4 genes for rotavir
Primer Sequence (5′ – 3′)
G-typing (VP7) first amplification
VP7-F ATG TAT GGT ATT GAA TAT A
VP7-R AAC TTG CCA CCA TTT TTT CC
G-typing (VP7) second amplification
G1 aBT1 CAA GTA CTC AAA TCA ATG A
G2 aCT2 CAA TGA TAT TAA CAC ATT T
G3 mG3 ACG AAC TCA ACA CGA GAG
G4 aDT4 CGT TTC TGG TGA GGA GTT G
G8 aAT8 GTC ACA CCA TTT GTA AAT T
G9 mG9 CTT GAT GTG ACT AYA AAT A
P-typing (VP4) first amplification
VP4-F TAT GCT CCA GTN AAT TGG
VP4-R ATT GCA TTT CTT TCC ATA AT
P-typing (VP4) second amplification
P[4] 2T-1 CTA TTG TTA GAG GTT AGA G
P[6] 3T-1 TGT TGA TTA GTT GGA TTC AA
P[8] 1T-1 TCT ACT TGG ATA ACG TGC
P[9] 4T-1 TGA GAC ATG CAA TTG GAC
P[10] 5T-1 ATC ATA GTT AGT AGT CGG
References: [35].gel with a 50-bp DNA ladder as a standard marker and
visualized by UV light after ethidium bromide-staining.
All these procedures were performed according to the
methods of WHO manuals [35].
Detection of co-infection with norovirus: xTAG® GPP assay
The xTAG® Gastrointestinal Pathogen Panel (xTAG®GPP)
(Luminex corporation, Austin, TX) is a qualitative multi-
plex PCR assay to detect simultaneously 15 different path-
ogens including norovirus in human stool samples. Solid
stool (100-150 μg), or 100 μl of liquid stool was added to a
Bertin SK38 Soil Mix Bead tube (BioAmerica Inc., Miami,
FL) containing 900 μl of NucliSENS lysis buffer (bioMér-
ieux, Durham, NC) [36]. RNA isolation for the xTAG®
GPP assay was performed on the QIAamp MinElute Virus
Spin kit (Qiagen, Hilden, Germany) [37]. A multiplex PCR
was prepared by adding the xTAG GPP Primer Mix
(Luminex corporation). PCR amplification cycling pa-
rameters were a reverse transcription (RT) step at 53°C
for 20 min followed by an enzyme activation step at
95°C for 15 min and then 38 cycles of 95°C for 30 s,
58°C for 30 s and 72°C for 30 s, and followed by a final
elongation step at 72°C for 2 min [38]. Following the
incubation of the RT-PCR products with the xTAG
GPP bead mix, streptavidin-PE conjugate and xTAG re-
porter buffer (Luminex corporation), the mixture wasus genotyping
Position PCR product (bp)
CC AC nt 51-71 881
nt 914-932
TG G nt 314-335 618
TC TGT G nt 411-435 521
G nt 250-269 682
nt 480-498 452
CG nt 178-198 754
C nt 757-776 179
nt 132-149 663
G nt 775-795
TC nt 474–494 362
nt 259–278 146
nt 339 –356 224
nt 385–402 270
nt 575–594 462
Table 2 Parameters and Vesikari clinical scoring system
Score
Parameters 0 1 2 3
Diarrhea
Frequency, per days 1-3 4-5 ≥6
Duration (days) 1-4 5 ≥6
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followed by 45 min at 45°C. Data acquisition and analysis
was performed on the MAGPIX instrument using xPO-
NENT 4.2 software: positive and negative results were
linked to a ratio between the target median fluorescence
intensity and the threshold. An internal control (bacterio-
phage MS2) was included in each specimen [39].Vomiting
Frequency, per days 0 1 2-4 ≥5
Duration (days) 1 2 ≥3
Body temperature (°C) <37.0 37.1-38.4 38.5-38.9 ≥39.0
Dehydration None (<5%) 5-10% >10%
Treatment None ORS HospitalizedDetection of co-infection with bacteria
Regarding the method of detection of co-infection with
bacteria, we performed conventional bacterial culture
method using all the stool samples according to the pre-
vious work [35,40-44].Clinical factors
Clinical factors that were associated with the rotavirus
genotyping included patient’s age (months), parents’
education, source of drinking water, duration of diarrhea
before hospitalization, type of diarrhea, family income
(monthly), type of milk, frequency of diarrhea, cough,
fever, antibiotic administration, body temperature, nutri-
tional state, co-bacterial infection, co-infection of upper
respiratory tract infection (URTI), results of bacterial










Severly wasted 19 21.6Severity of diarrhea
The severity of diarrheal disease is related to clinical
symptoms such as vomiting, the frequency of diarrhea,
increase in body temperature, dehydration requiring
intravenous rehydration fluid administration, the need
for hospitalization, and the number of days the patient
has been suffering from diarrhea. The diagnosis of the
severity of diarrhea in this study was done at the time
of recruitment of study subjects, which was when the
diarrhea patients were admitted to the hospital. The se-
verity of diarrhea was measured through the scoring
system designed by Ruuska and Vesikari, which was
tested for reliability and internal validity by Freedman,








Statistical analysis was performed using SPSS statistics
17.0 (WinWrap® Basic, Polar Engineering and Consult-
ing). Descriptive statistics using means, medians, stand-
ard deviation and confidence intervals were performed
on all variables where appropriate. Inferential analysis
was performed using the chi square and t-test.Never 13 14.8
<6 months 42 47.7
6-12 months 15 17.0
>12 months 18 20.5Results
Eighty-eight samples positive for rotavirus out of the 220
fecal samples were analyzed using immunochromato-
graphic methods.Patient characteristics
Patient characteristics are shown in Tables 3 and 4. In
brief, 51 (58%) were male and 37 (42%) were female.
The age (months) was 14.6 ± 11.0. The most prevalent
family income was US$ 90–179 in 41 patients (46.6%),
followed by US$ 45–89 in 31 patients (35.2%). The
prevalent source of drinking water was mineral water in
50 patients (56.8%), followed by tap water in 33 patients
(37.5%). Frequency of diarrhea was 6.22 ± 3.85 times a
day. Cough was seen in 25 patients (28.4%) and fever
was seen in 72 patients (81.8%). Type of milk was
Table 4 Clinical manifestations
Variable N % Mean SD
Duration of diarrhea (hours) 55.54 30.73
Diarrhea frequency over 24 hours (each) 6.26 3.85
Vomiting 67 77.0
Duration of vomiting (days) 1.82 1.10
Vomiting frequency over 24 hours (each) 4.76 3.64






With URTI* (cough/cold) 25 28.7
Dehydration
No dehydration 0 0
Some dehydration 78 88.6
Severe dehydration 10 11.4
Coinfections 64 72.7
Concomitant pathogens
Eschelichia coli 37 42.5
Klebsiella spp. 24 27.6
Enterobacter spp. 3 3.4
*URTI: Upper respiratory tract infection.
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feeding + formula milk (31.8%). Antibiotics were admin-
istered in 20 patients (22.7%). Nutrition status was
assessed as normal (55.7%), wasted (17.0%) and severely
wasted (21.6%).Figure 1 Gel electrophoreses from stool samples. PCR amplification resul
VP7 RT-PCR product: positive control), lane 2 (G1, 618 bp), lane 4 (G4, 452 bp)
negative control.Co- infection pathogens
Co-bacterial infection was seen in 64 patients (72.7%).
The most prevalent bacteria was Escherichia coli (37/64,
57.8%) followed by Klebsiella (24/64, 37.5%). Co-viral in-
fection was seen in 20 patients (22.7%) with rota + noro
seen in 17 patients (85.0%) and rota + adeno + noro seen
in 3 patients (15.0%).Rotavirus typing
Rotavirus typing in VP7 and VP4 was classified as com-
mon (G1, G2, G3, G4 and G9 (VP7) and P[4], P[6] and
P[8] (VP4)) and uncommon (others) typing. Common
typing was detected in 68.2% in VP7 and in 85.2% in
VP4. The predominant VP7 genotyping (G type) was G2
(31.8%), followed by G1 (29.5%), G9 (11.4%), G4G9
(8.0%), and G1G2 (4.6%). As to VP4 genotyping (P typ-
ing), P[4] was predominant (31.8%), followed by P[6]
(27.3%), P[8] (26.1%), P[9] (4.5%) and P[6]P[8] (4.5%).
The typing was confirmed by PCR (Figures 1, 2 and 3).
Combinations of G and P typing were classified as com-
mon (G1P[6], G1P[8], G2P[4], G2P[6], G3P[6], G4P[6]
and G4P[8]) or uncommon types as well. Common typing
was detected in 52.3% (Table 5). Uncommon typing data
are also shown in Table 5. The predominant common type
was G2P[4] (19.3%), followed by G1P[6] (12.5%) and G1P
[8] (11.4%). and the predominant uncommon types were
G9P[4] (4.6%) and G1P[4] (4.5%).
Common genotype combination groups included 7 geno-
type variations and uncommon genotype groups included
25 genotype variations. G2P[4] genotypes predominated
among the common genotype groups. The highest number
of uncommon genotype groups found were G1P[4] and
G9P[4]. Twenty-five variations of uncommon genotype
combinations were found in small quantities (Table 5).t for G-type. Lane M: DNA Step Ladder marker, lane 1 (881 bp, full length
, lane 5 (G2, 521 bp), lane 6 (G3, 682 bp), lanes 7 and 8 (G9, 179 bp). (−):
Figure 2 Gel electrophoreses from stool samples. PCR amplification result for P-type. Lane M (DNA Step Ladder), lane (+): positive control (663 bp, full
length VP4 gene), lanes 1 (P[4], 362 bp), lanes 2 and 4 (P[8], 224 bp), lane 3 (P[10], 462 bp), lane 5 (P[9], 270 bp) and lane 6 (P[6]P[8], 146 bp and 224 bp).
Lane (−): negative control.
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uncommon G-type rotaviruses was higher than for
common GP-type and common G-type with statistically
significant differences. P-types showed no significantly
differences in total severity score between common and
uncommon genotype groups (Table 6).Rotavirus typing and diarrhea
G3, G4 and G9 were significantly correlated with severe
diarrhea (p = 0.009) in our multivariate analyses and
with frequency of diarrhea (>10 times a day) (p = 0.045)Figure 3 Gel electrophoreses from stool samples. PCR amplification resul
full length VP4 gene), lane 7 (P[6]P[8], 146 bp and 224 bp), lane 8 (P[6], 146 bp
Lanes (−): negative control.in univariate analyses, but there was no significant
correlation between P typing and severity of diar-
rhea. Regarding the combination of G and P typing,
G2P[4] was significantly correlated with severe diar-
rhea in multivariate analyses (p = 0.029) (Tables 7, 8
and 9).Discussion
Rotavirus infection is a common cause of pediatric acute
diarrhea especially in developing countries [4-6], and the
most common cause of non-bacterial gastroenteritis int for P-type. Lane M (DNA Step Ladder), lane (+): positive control (663 bp,
) , lane 9 and 10 (P[9], 270 bp), and lane 11 (P[4]P[9], 362 bp and 270 bp).
Table 5 Common and uncommon combination
genotyping (G-type and P-type)









Uncommon genotyping N % N %
G1P[4] 4 4.5 G2P[4]P[8] 1 1.1
G1G2P[6] 2 2.3 G2P[6]P[8] 2 2.3
G1G2P[8] 2 2.3 G4P[4] 1 1.1
G1G4G9P[8] 1 1.1 G4G9P[4] 1 1.1
G1G4P[4] 1 1.1 G4G9P[6] 1 1.1
G1G4P[6] 1 1.1 G4G9P[8] 3 3.4
G1G9P[8] 1 1.1 G4G9P[10] 1 1.1
G1P[4]P[8] 1 1.1 G4G9P[4]P[9] 1 1.1
G2P[8] 2 2.3 G9P[4] 4 4.5
G2P[9] 2 2.3 G9P[6] 2 2.3
G2G4P[8] 1 1.1 G9P[8] 2 2.3
G2G4P[9] 2 2.3 G9P[6]P[8] 2 2.3
G2P[10] 1 1.1
Subtotal n = 42 (47.7)
Table 6 Correlation of total severity score to rotavirus
genotypes
Variable Type N Mean total score SD p-values
GP-type Uncommon 41 11.56 1.58 0.000
Common 47 9.06 1.82
G-type Uncommon 28 12.00 1.41 0.000
Common 60 9.40 1.87
P-type Uncommon 13 10.85 1.73 0.256*
Common 75 10.12 2.17
*Mann–Whitney test, p < 0.05 (significant); bold: statistically significant.
Table 7 Correlation of severity of diarrhea with
genotypes
Univariate Multivariate
Genotype N (%) OR p OR p
G1 34 (38.6) 2.08 0.100
G2 33 (37.5) 0.25 0.004 0.36 0.089
G3, G4, G9 30 (34.1) 5.22 0.001 10.75 0.009
P4 31 (35.2) 0.85 0.722
P6 28 (31.8) 0.61 0.281
P8 29 (33.0) 1.93 0.154
P9, P10 7 ( 8.0) 1.51 0.605
Bold: statistically significant. OR: odds ratio.
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veloped countries. The positive rate for rotavirus varies
between countries and regions, and the different detection
rates may be explained by different study conditions, such
as the season of the year or sampling methods.
We characterized the VP7 (G genotype) and VP4 (P
genotype) gene segments in this study along with pa-
tients’ backgrounds and symptoms, and then identified
the most common rotavirus combinations in our study.
The rotavirus genotypes identified were very diverse.
Genotypic variations were classified as common and un-
common based on descriptions by Kobayashi et al. [8].
We found genotype G2P[4] to be the dominant genotype
with an overall prevalence of 19.3% in the subjects stud-
ied. As mentioned above, G1P[8], G2P[4], G3P[8], and
G4P[8] were the four most common dominant geno-
types in the world previously. The prevalence of each
genotype was 52%, 11%, 3%, and 8% [10,11] respectively.
These results differ from the studies by Sunarto et al.
who found G1P[6] genotype as the dominant genotype
[17]. Putnam et al. identified G2P[4] as the predomin-
ant genotype in the common genotype group, followedby G1P[6] [14]. Assuming a similarity in identification
techniques, the difference in results may indicate that
genotype prevalence in circulating rotaviruses may
change periodically subject to natural fluctuations as re-
ported by Gentsch et al. It is recommended that rota-
virus vaccination programs conduct surveillance on an
ongoing basis, including before and after implementa-
tion of vaccination programs [45]. Tate et al. suggested
that the genotypes found to be circulating before the
vaccination period should be used as a reference for the
composition of the rotavirus vaccine, in order to pro-
duce vaccines with high efficacy [46]. Monitoring of
genotypic variability after rotavirus vaccination makes it
possible to identify genotypes that evolve in response to
the selection pressure of the vaccine to emerge as new
phenotypes that are immune to older vaccines. The
emergence of immune genotypes has to be watched for
and accommodated in the design of the next vaccines
[31].
In this study, 64 subjects (72.7%) were found to be co-
infected with bacteria. The commonest pathogen found
concomitantly with rotavirus infection was E. coli. A sys-
tematic review by Grimprel et al. drawing on 173 English
language journals from 1989 to 2006 reporting research in
various countries around the world stated that the co-
occurrence of diarrhea pathogen in the studied populations
Table 8 Correlation of severity of diarrhea with combination genotypes
Univariable Multivariable
Genotype N (%) OR p OR p
G1P4 6 (6.8) 6.08 0.106
G1P6 14 (15.9) 1.11 0.853
G1P8 15 (17.0) 1.31 0.634
G1P9, G1P10 0 ( 0.0)
G2P4 18 (20.5) 0.94 0.003 0.95 0.029
G2P6 7 ( 8.0) 0.41 0.303
G2P8 8 ( 9.1) 3.67 0.125
G2P9, G2P10 5 ( 5.7) 0.72 0.723
G3P4, G4P4, G9P4 10 (11.4) 5.18 0.046 9.22 0.087
G3P6, G4P6, G9P6 10 (11.4) 1.11 0.879
G3P8, G4P8, G9P8 11 (12.5) 3.37 0.089
G3P9, G3P10, G4P9, G4P10, G9P9, G9P10 4 (4.5) 9.68 0.134
Bold: statistically significant. OR: odds ratio.
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epidemiology, economic development, and hygiene condi-
tions [32]. A cohort study by Souza et al. in 154 children
under 5 years suffering from acute diarrhea in Brazil re-
vealed that 16.2% of rotavirus infections had co-infection
with bacteria, particularly pathogenic E. coli [31].
Genotyping results were significantly associated with
the severity of diarrhea using Vesikari symptom scores.
In multivariate analyses, G3, G4 and G9 correlated sig-
nificantly with severe diarrhea and frequent diarrhea
and G2P[4] showed a significant correlation with severityTable 9 Correlation of G3, G4, and G9 genotypes with
risk factors except for severity of diarrhea
Univariate
Risk factor N (%) OR p
Gender (female) 37 (42.0) 1.08 0.860
Age >10 years 56 (63.6) 1.53 0.374
Co-infection with other virus 20 (22.7) 0.40 0.139
Temperature (>38°C) 26 (29.5) 1.31 0.576
Co-infection with bacteria 64 (72.7) 0.64 0.360
Cough 26 (29.5) 1.31 0.576
Type of diarrhea 68 (77.3) 1.74 0.333
Frequency of diarrhea (>10 times a day) 16 (18.2) 3.12 0.045
Hand-washing 3 ( 3.4) - -
Mother hand-washing 8 ( 9.1) 1.18 0.831
Vomiting 68 (77.3) 1.27 0.661
Lavatory 11 (12.5) 1.73 0.399
Fever 72 (81.8) 1.17 0.791
Bold: statistically significant.of diarrhea. Further examination with longer periods of
surveillance should be continued to monitor trends in this
disease.
We would like to emphasize the limitations of this
study. First, the number of cases and the study period
are not enough to draw definitive conclusions. None-
theless, these data are of importance since the studies
in eastern Indonesia are lacking despite the prevalence
of this disease in this region and its standing as a social
issue in Indonesia. Secondly, seasonal data on viral iso-
lation may show the trends in the spread of pathogens.
Long-term regional surveillance is needed to overcome
these limitations.Conclusions
The present study reports the current situation for acute
diarrhea caused by rotavirus in infants or younger chil-
dren in east Indonesia, Surabaya. Genotype G2P[4] has
the highest prevalence, and G3, G4 and G9 and G2P[4]
combination genotype were found to be associated with
severe and frequent diarrhea. Further long-term studies
as well as surveillance programs are necessary for over-
coming rotaviral disease.Competing interests
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